Displaying 101 - 110 of 1288 Results
News Medical Device Lawsuits

Rhode Island jury awards $4.8 million verdict to man injured by Bard hernia mesh

August 29, 2022 | by: Motley Rice
Medical device manufacturer C.R. Bard is liable for severe gastrointestinal injuries a Hawaii man developed after receiving the company’s Ventralex™ mesh in a hernia repair. Motley Rice LLC, one of the nation’s largest plaintiffs’ litigation firms, represented plaintiff Paul Trevino in the month-long jury trial,…
News

2023 editions of The Best Lawyers in America® and Best Lawyers: Ones to Watch in America™ include 37 Motley Rice lawyers

August 24, 2022 | by: Motley Rice
Four Motley Rice member attorneys were recognized as a 2023 “Lawyer of the Year” in the 29th edition of The Best Lawyers in America. The guide includes 22 of the firm’s attorneys in its Best Lawyers® list, and included another 15 Motley Rice lawyers in its 2023 Best Lawyers: Ones to Watch in America list. In the 29th…
Blog Toxic Exposure

Now law, Honoring our PACT Act expands resources for victims of military toxic exposure | Causes, Not Just Cases®

August 10, 2022 | by: Kevin R. Dean
President Biden signed into law the Honoring our PACT Act. This impactful piece of legislation is aptly named, signifying the promise we as a nation make (but so often fail to live up to) to support the members of our armed forces who selflessly put their lives on the line to protect us and our freedoms. 
News Personal Injury Lawsuits

Motley Rice files economic loss suit against ARC, automakers alleging deadly airbag defect in millions of vehicles

August 3, 2022 | by: Motley Rice
Motley Rice, filed a proposed class action this week against global parts manufacturer ARC Automotive and multiple automakers. The suit seeks compensation for vehicle owners and lessees for a deadly airbag inflator defect that are believed to be in more than 30 million vehicles across the country.
Blog Public Client

Nearly $4.25 billion Teva settlement a sign opioid litigation strategy is working to abate the crisis, help communities recover | Causes, Not Just Cases®

July 26, 2022 | by: Joseph F. Rice
Generic opioid manufacturer Teva Pharmaceuticals agreed today to pay nearly $4.25 billion to aid communities nationwide that are burdened with the effects of the opioid crisis.
News Transportation

Amtrak train carrying 243 passengers derails in Missouri

June 27, 2022 | by: Motley Rice
An Amtrak passenger train that was traveling from Los Angeles to Chicago derailed in Mendon, Mo., on June 27, 2022 after hitting a dump truck at a public crossing. 
News Toxic Exposure

Fidelma Fitzpatrick appointed to leadership for Paraquat weed killer mass tort in Philadelphia

June 10, 2022 | by: Motley Rice
Philadelphia Judge Abbe Fletman appointed two Motley Rice attorneys to lead dozens of cases filed for farmers, railroad workers and others who allege toxic weed killer Paraquat caused them to develop Parkinson’s Disease.
News Motley Rice - Firm Wide

Motley Rice nationally ranked for product liability in 2022 Chambers USA guide

June 3, 2022 | by: Motley Rice
Chambers USA recognized Motley Rice as a nationally ranked plaintiffs’ law firm today in the launch of its 2022 guide. The guide ranked Motley Rice as Band 1 in the category of USA – Nationwide: Product Liability: Plaintiffs. Motley Rice is one of only three firms to receive the ranking.
News Public Client

West Virginia negotiates more than $260 million in preliminary settlements with opioid manufacturers Allergan, J&J, Teva, ending trial

May 26, 2022 | by: Motley Rice
West Virginia, with the support of Motley Rice as outside counsel, has reached a $161.5 million preliminary settlement with opioid manufacturers Allergan and Teva.
News Public Client

Washington state secures more than $500 million in settlement with nation's "Big Three" opioid distributors

May 5, 2022 | by: Motley Rice
The State of Washington, represented by outside trial counsel Motley Rice LLC, reached a preliminary settlement worth more than $500 million on May 3, 2022, roughly five months into what was one of the first state cases to go to trial against AmerisourceBergen, Cardinal Health and McKesson.